Moderna plans multi-pronged approach to tackling virus variants
Moderna plans multi-pronged approach to tackling virus variants The company said it was making new capital investments to increase manufacturing capacity and said that next year it plans to produce 1.4 billion doses, up from an earlier estimate of 1.2 billion doses. (Reuters)Premium . Updated: 25 Feb 2021, 07:15 AM IST Bloomberg Moderna says it had completed manufacturing doses of a new version of its Covid-19 vaccine modified to target the South Africa strain, or B.1.351, and shipped it to researchers at the National Institutes of Health for clinical study Share Via Read Full Story Modern...